T cells from tumor-bearing mice immunized with VP1/CA or VP1/RA shown increased secretion of IL-2, IFN-γ, and TNF-α than T cells from untreated tumor-bearing mice in this study, which were correlated with in vivo antitumor effects induced by VP1/CA or VP1/RA. The gene discussed is IL2; the disease is neoplasm.